Teleflex has received the US Food and Drug Administration (FDA) market clearance for its Arrow NextStep Antegrade Chronic Hemodialysis Catheter.
The NextStep Antegrade Chronic Hemodialysis Catheter is designed to attain long-term vascular access for hemodialysis and apheresis and is indicated for use in adult patients.
The catheter includes a step-tip catheter’s ease of insertion and a split-tip catheter’s sustained high flow.
Teleflex chairman, president and CEO Benson Smith said the Arrow NextStep Antegrade Catheter is designed to provide some of the benefits of step-tip and split-tip catheters in a single solution.
"We are confident that it will become a preferred option for clinicians who use the antegrade tunneling procedure to insert chronic hemodialysis catheters," Smith said.
Teleflex also recently expanded its vascular access product offerings with the acquisition of the VasoNova VPS vascular positioning system, a central venous catheter tip navigation system.